Cargando…
Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
BACKGROUND: Cyclin D1 gene regulates cell cycle and plays an important role in the tumorigenesis of human cancers. The association between cyclin D1, clinicopathologic parameters and prognosis in oral cavity squamous cell carcinoma (OSCC) is inconclusive. METHODS: A total of 264 male OSCCs were exam...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312822/ https://www.ncbi.nlm.nih.gov/pubmed/22336657 http://dx.doi.org/10.1186/1477-7819-10-40 |
_version_ | 1782227889123491840 |
---|---|
author | Huang, Shiang-Fu Cheng, Sou-De Chuang, Wen-Yu Chen, I-How Liao, Chun-Ta Wang, Hung-Ming Hsieh, Ling-Ling |
author_facet | Huang, Shiang-Fu Cheng, Sou-De Chuang, Wen-Yu Chen, I-How Liao, Chun-Ta Wang, Hung-Ming Hsieh, Ling-Ling |
author_sort | Huang, Shiang-Fu |
collection | PubMed |
description | BACKGROUND: Cyclin D1 gene regulates cell cycle and plays an important role in the tumorigenesis of human cancers. The association between cyclin D1, clinicopathologic parameters and prognosis in oral cavity squamous cell carcinoma (OSCC) is inconclusive. METHODS: A total of 264 male OSCCs were examined for cyclin D1 protein expression using immunohistochemistry (IHC). The expression levels of cyclin D1 were defined as overexpression when more than 10% of tumor cells displayed nuclear staining with moderate to strong intensity. RESULTS: Overexpression of cyclin D1 was found in 97 (36.7%) OSCCs. Cyclin D1 protein overexpression was significantly associated with lymph node metastasis (P = 0.002), tumor cell differentiation (P = 0.031) and tumor stage (P = 0.051), but not associated with age onset, cigarette smoking, alcohol drinking, or areca quid chewing. Overexpression of cyclin D1 was also significantly associated with poor clinical outcomes in terms of disease-free survival (DFS, P = 0.002) and overall survival (OS, P < 0.001). The effects of cyclin D1 protein overexpression on DFS (hazard ratio (HR) = 1.540; 95% confidence interval (CI), 1.068 - 2.222) and OS (HR = 1.702; 95% CI, 1.168 - 2.480) were still existed after adjusting for clinicopathological paremeters (such as age, primary tumor status, tumor cell differentiation, and lymph node metastasis) using logistic multivariate analysis. CONCLUSION: Cyclin D1 protein worked as an independent prognostic factor and can be as a biomarker for the aggressiveness of OSCC. |
format | Online Article Text |
id | pubmed-3312822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33128222012-03-27 Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma Huang, Shiang-Fu Cheng, Sou-De Chuang, Wen-Yu Chen, I-How Liao, Chun-Ta Wang, Hung-Ming Hsieh, Ling-Ling World J Surg Oncol Research BACKGROUND: Cyclin D1 gene regulates cell cycle and plays an important role in the tumorigenesis of human cancers. The association between cyclin D1, clinicopathologic parameters and prognosis in oral cavity squamous cell carcinoma (OSCC) is inconclusive. METHODS: A total of 264 male OSCCs were examined for cyclin D1 protein expression using immunohistochemistry (IHC). The expression levels of cyclin D1 were defined as overexpression when more than 10% of tumor cells displayed nuclear staining with moderate to strong intensity. RESULTS: Overexpression of cyclin D1 was found in 97 (36.7%) OSCCs. Cyclin D1 protein overexpression was significantly associated with lymph node metastasis (P = 0.002), tumor cell differentiation (P = 0.031) and tumor stage (P = 0.051), but not associated with age onset, cigarette smoking, alcohol drinking, or areca quid chewing. Overexpression of cyclin D1 was also significantly associated with poor clinical outcomes in terms of disease-free survival (DFS, P = 0.002) and overall survival (OS, P < 0.001). The effects of cyclin D1 protein overexpression on DFS (hazard ratio (HR) = 1.540; 95% confidence interval (CI), 1.068 - 2.222) and OS (HR = 1.702; 95% CI, 1.168 - 2.480) were still existed after adjusting for clinicopathological paremeters (such as age, primary tumor status, tumor cell differentiation, and lymph node metastasis) using logistic multivariate analysis. CONCLUSION: Cyclin D1 protein worked as an independent prognostic factor and can be as a biomarker for the aggressiveness of OSCC. BioMed Central 2012-02-16 /pmc/articles/PMC3312822/ /pubmed/22336657 http://dx.doi.org/10.1186/1477-7819-10-40 Text en Copyright ©2012 Huang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Huang, Shiang-Fu Cheng, Sou-De Chuang, Wen-Yu Chen, I-How Liao, Chun-Ta Wang, Hung-Ming Hsieh, Ling-Ling Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma |
title | Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma |
title_full | Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma |
title_fullStr | Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma |
title_full_unstemmed | Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma |
title_short | Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma |
title_sort | cyclin d1 overexpression and poor clinical outcomes in taiwanese oral cavity squamous cell carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312822/ https://www.ncbi.nlm.nih.gov/pubmed/22336657 http://dx.doi.org/10.1186/1477-7819-10-40 |
work_keys_str_mv | AT huangshiangfu cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma AT chengsoude cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma AT chuangwenyu cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma AT chenihow cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma AT liaochunta cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma AT wanghungming cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma AT hsiehlingling cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma |